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Neurons are extraordinarily large and highly polar-
ized cells that require rapid and efficient communica-
tion between cell bodies and axons over long
distances. In peripheral neurons, transcripts are
transported along axons to growth cones, where
they are rapidly translated in response to extrinsic
signals. While studying Tp53inp2, a transcript highly
expressed and enriched in sympathetic neuron
axons, we unexpectedly discovered that Tp53inp2
is not translated. Instead, the transcript supports
axon growth in a coding-independent manner.
Increasing evidence indicates that mRNAsmay func-
tion independently of their coding capacity; for
example, acting as a scaffold for functionally related
proteins. The Tp53inp2 transcript interacts with the
nerve growth factor (NGF) receptor TrkA, regu-
lating TrkA endocytosis and signaling. Deletion of
Tp53inp2 inhibits axon growth in vivo, and the de-
fects are rescued by a non-translatable form of the
transcript. Tp53inp2 is an atypical mRNA that regu-
lates axon growth by enhancing NGF-TrkA signaling
in a translation-independent manner.
INTRODUCTION
Neurons are highly morphologically complex cells that require
the expression of a large number of genes encoding proteins
that support growth, branching and synaptic functions in den-
drites, and growth cone migration, extension, and regeneration
in axons (Andreassi et al., 2018; Terenzio et al., 2017). Neuronal
cells rely on asymmetric localization of mRNAs to compartmen-
talize gene expression, a mechanism shared with most
eukaryotic cells (Martin and Ephrussi, 2009). Transcripts are
transported to dendrites and axons, where they can be rapidly
translated in response to extrinsic signals, such as synaptic ac-
tivity, neurotrophic factors, guidance cues, and injury (Andreassi
et al., 2010; Cajigas et al., 2012; Gumy et al., 2011; Riccio, 2018;Neuron 102, 1
This is an open access article undSambandan et al., 2017; Terenzio et al., 2018). Genome-wide
screens performed on RNA isolated from either dendrites or
axons revealed that thousands of transcripts are asymmetrically
localized in neurons (Andreassi et al., 2010, 2019; Cajigas et al.,
2012; Gumy et al., 2011; Shigeoka et al., 2016). However, how
peripherally localized transcripts influence axon growth and
whether they may function independently of their translational
capacity remains largely unknown.
Here we show that Tp53inp2, one of the most abundant and
enriched mRNA transcripts in axons, is not translated in sympa-
thetic neurons and regulates axon growth in a coding-indepen-
dent manner. The unusually long 30 UTR of Tp53inp2 maintains
the transcript in a translationally repressed state, possibly
conferring to the transcript unique, neuron-specific roles. Impor-
tantly, we demonstrate that Tp53inp2 interacts with the nerve
growth factor (NGF) receptor TrkA, promoting receptor traf-
ficking and intracellular signaling. Analysis of transgenic mice
lacking Tp53inp2 demonstrated that the gene is required for
axon growth and sympathetic target innervation. Noticeably,
the defects were rescued by a translation-deficient Tp53inp2
transcript, indicating that, at least in sympathetic neurons,
Tp53inp2 functions independently of translation. Thus, our study
reveals the essential role of the Tp53inp2 transcript in regulating
sympathetic neuron growth and innervation and represents the
first evidence of an axonal mRNA capable of directly modulating
NGF-TrkA signaling.
RESULTS AND DISCUSSION
The Tp53inp2 Transcript Is Highly Expressed, but Not
Translated, in Sympathetic Neuron Axons
Eukaryotic mRNAs include a coding sequence (CDS) encoding
the protein and flanking UTRs of variable length, called 50 and
30 UTRs, that harbor regulatory elements that determine tran-
script localization, stability, and translation (Andreassi and Ric-
cio, 2009; Lianoglou et al., 2013). To obtain a comprehensive
characterization of the 30 UTR transcript isoforms expressed
in sympathetic neuron axons, we performed 30 end RNA
sequencing (RNA-seq) on mRNA isolated from either axons or
cell bodies of rat sympathetic neurons cultured in compartmen-
talized chambers (Andreassi et al., 2019). In this model system,
NGF is added only to the lateral axonal compartment, creating–11, May 8, 2019 ª 2019 The Authors. Published by Elsevier Inc. 1





Figure 1. Tp53inp2 Translation Is Repressed in Sympathetic Neurons
(A) Western blot of PC12 lysates transfected with Tp53inp2CDS-2xFLAG and Tp53inp2 siRNA, as indicated (n = 3).
(B) Western blot of lysates of HeLa cells treated with cycloheximide (CHX) for the indicated time (n = 3).
(C) qRT-PCR of Tp53inp2 and b-actin in polysomal fractions from sympathetic neurons lysates; paired two-tailed t test (n = 3, **p < 0.01).
(D–F) Pseudo-selected reaction monitoring traces for the detection of a Tp53inp2 tryptic peptide in cultured sympathetic neuron axon (E) or cell body (F) samples
and in an immunoprecipitatedmyc-Tp53inp2 control (D). The four traces represent the 4most abundant fragments of the Tp53inp2 peptide ALHHAAAPMoxPAR.
Arrows indicate where at least three transitions are detected at the same retention time, indicating peptide presence. Top value on trace, retention value; bottom
value, mass to charge ratio (m/z).
(legend continued on next page)
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neurotrophins from target tissues (Kuruvilla et al., 2000; Riccio
et al., 1997). mRNAwas subjected to two rounds of linear poly(A)
amplification before sequencing to enrich for 30 UTRs (Andreassi
et al., 2019; Andreassi et al., 2010). Tp53inp2 was the most
abundant transcript in axons, accounting for almost one-third
of the reads (Figures S1A and S1B). The transcript is unusual
in that the 30 UTR is over 3,000 nt long (3,121 nt), accounting
for nearly 80%of the transcript length, whereas the open reading
frame (ORF) is 666 nt long, encoding a small protein of predicted
low complexity. Although the Tp53inp2 protein has been impli-
cated in the regulation of autophagy in skeletal muscle fibers
and other mammalian cell lines (Nowak et al., 2009; Sala et al.,
2014), extensive attempts to detect the endogenous Tp53inp2
protein in PC12 cells and sympathetic neurons using either
homemade, commercial, or previously published antibodies
were unsuccessful. Western blotting of PC12 cells transfected
with a vector expressing the CDS of Tp53inp2 showed that, un-
der these conditions, the transcript was translated and easily de-
tected (Figure 1A; Figures S1C and S1D). Co-transfection with a
small interfering RNA (siRNA) that efficiently inhibited Tp53inp2
expression completely abolished the signal (Figure 1A), indi-
cating the specificity of the antibodies. Importantly, we tested
several cell types and confirmed that endogenous Tp53inp2
was expressed in HeLa cells (Xu et al., 2016) and that the
protein was stable, with a half-life of at least 4 h (Figure 1B;
Figure S1E).
To further investigate whether Tp53inp2mRNAwas translated
in sympathetic neurons, we performed polysome fractionation
(Johannes and Sarnow, 1998). Although not devoid of limita-
tions, the technique allows an accurate prediction of transcript
translation rates. qRT-PCR of the Tp53inp2 transcript associ-
ated with either polyribosomes or monosomes revealed that, in
sympathetic neurons, a large fraction of Tp53inp2 mRNA co-
sedimented with the monosomal fraction, whereas the efficiently
translated transcript b-actin was mostly associated with poly-
somes (Figure 1C; Figure S1F). Because monosomes in yeast
can translate transcripts containing an ORF of up to 600 nt
(Heyer and Moore, 2016), we further investigated, using mass
spectrometry, whether Tp53inp2 protein was expressed in sym-
pathetic neurons. Three proteotypic peptides identified by a
data-dependent analysis of immunoprecipitated Tp53inp2
were selected for high-sensitivity detection in targeted mode
(Table S1). Targeted mass spectrometry performed either on
severed axons or cell bodies of sympathetic ganglia explants
(superior cervical ganglia [SCG]) confirmed that Tp53inp2 pep-
tides were not present in axons (Figures 1D–1F; Figure S1G).
Very small signals corresponding to ALHHAAAPMoxPAR and
HQGSFIYQPCQR fragment ions were detected at the limit of
the signal-to-noise ratio only in cell bodies (Figure 1F; Fig-
ure S1G). It should be noted however, that SCG explants contain
few non-neuronal cells that may account for the Tp53inp2 pep-
tides detected in the cell body samples. Thus, although we(G) Left: western blot of PC12 cells co-transfectedwith GFP fusion constructs con
densitometry of GFP protein levels was normalized bymCherry levels and then fur
the mean GFP protein amount of the 1.2-kb construct. Ordinary one-way ANOV
Data are presented as average ± SEM. See also Figure S1.cannot exclude the possibility that the Tp53inp2 transcript is
translated at extremely low levels in cell bodies of sympathetic
neurons, Tp53inp2 protein was undetectable in axons using
three distinct sensitive technical approaches.
The unexpected finding that, despite its abundance, Tp53inp2
mRNA was not synthesized into a protein prompted us to inves-
tigate the mechanisms that maintain the transcript in a transla-
tionally silent state in sympathetic neurons. Because vectors
expressing only the coding region of Tp53inp2 were translated
(Figure 1A; Figures S1C and S1D), we reasoned that the
Tp53inp2 30 UTR may harbor regulatory elements that inhibit
translation. To this end, we generated expression vectors car-
rying the 50 UTR of Tp53inp2 upstream of the coding region of
GFP and followed by either the full-length (3,100 nt) or trun-
cated forms (2,200 nt and 1,200 nt, respectively) of the
Tp53inp2 30 UTR. Although there were some differences in the
expression levels of one vector (Figure S1I), when relative
mRNA expression was taken into account, shortening of the
30 UTR correlated with substantial relief of translational inhibition
(Figure 1G; Figure S1H). A possible implication of these results is
that cells expressing Tp53inp2 protein also express a Tp53inp2
transcript harboring a shorter 30 UTR. Indeed, qRT-PCR per-
formed on RNA isolated from either sympathetic neurons or
HeLa cells revealed that an isoform bearing a shorter 30 UTR
was predominantly expressed in HeLa cells (Figure S1J). These
findings indicate that elements contained within the longer
30 UTRmay be responsible for maintaining the transcript transla-
tionally silent in sympathetic neurons.
The Tp53inp2 Transcript Interacts with the TrkA
Receptor to Mediate NGF Signaling
Recent studies have shown that 30 UTRs may have a more flex-
ible role in regulating gene expression than previously thought
(Andreassi et al., 2018; Mayr, 2017). In hippocampal neurons,
for example, an E3 ubiquitin ligase isoform expressing a short
30 UTR (Ube3a1) inhibits dendritogenesis in a coding-indepen-
dent manner by competing with endogenous Ube3a for miR-
134 binding (Valluy et al., 2015). Moreover, in cancer cell lines,
the long 30 UTR of the CD47 transcript acts as a scaffold for
RNA binding proteins (RBPs) and determines the translocation
of the CD47 protein to the plasma membrane (Berkovits and
Mayr, 2015).
In axons,NGFbinds to its cognate receptor TrkAand, following
receptor dimerization and autophosphorylation, ligand-receptor
complexes are internalized within endosomes and retrogradely
transported to the cell bodies (Harrington andGinty, 2013; Yama-
shita and Kuruvilla, 2016). Signaling endosomes regulate axon
growth and are transported long-distance to somato-dendritic
compartments tomodulate synapse assembly and activate tran-
scription (Lehigh et al., 2017; Scott-Solomon and Kuruvilla,
2018). Given the lack of translation, we reasoned that in sympa-
thetic neurons, the Tp53inp2 transcript could influence NGF
signaling in a coding-independent manner. We first investigatedtaining Tp53inp2 30 UTR 3.1, 2.2, or 1.2 kb and anmCherry control vector. Right:
ther normalized by levels ofGFPmRNA. Values are expressed as percentage of
A, Tukey’s multiple comparisons test (n = 5, *p < 0.05, ***p < 0.001).
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axons by performing RNA immunoprecipitation (RIP) on sympa-
thetic neurons. Remarkably, the pan-Trk antibody immunopre-
cipitated the Tp53inp2 transcript, and the interaction was greatly
increased in response toNGFstimulation (Figure 2A; FigureS2A).
The cognate receptor TrkB also interacted with Tp53inp2 in
mouse cortical neurons (Figure 2B), whereas, in sympathetic
neurons, the highly abundant axonal transcript IMPA1-L was
not immunoprecipitated (Andreassi et al., 2010; Figure S2A).
Both transcripts were immunoprecipitated by the neuron-spe-
cific RBP HuD (Figures S2B and S2C), and endogenous HuD
and TrkA co-immunoprecipitated in sympathetic neurons (Fig-
ure S2D), suggesting that HuD may mediate TrkA binding to the
Tp53inp2 transcript. As a control, we performed RIP of Tp53inp2
with another transmembrane protein, NCAM, and found no sig-
nificant interaction (Figures S2E and S2F).
Next, we asked whether the Tp53inp2 transcript influences
NGF signaling in sympathetic neurons. To this end, we gener-
ated transgenic mice carrying a floxed allele of Tp53inp2, where
exons 2 and 3 are flanked by loxP sites (Tp53inp2fl/fl mice) (Fig-
ure S2G). To assess the effects of Tp53inp2 loss on NGF
signaling in axons, SCG explants isolated from Tp53inp2fl/fl
mice on postnatal day 0.5 (P0.5) were infected with either an
adenoviral vector expressing the Cre recombinase to acutely
delete Tp53inp2 (Figure S2H) or a LacZ virus as a control. Cell
bodies were mechanically severed, and the isolated axons
were stimulated with NGF. Axon protein lysate was either immu-
noblotted for the canonical signaling effectors Erk1-2 and Akt or
subjected to immunoprecipitation with a phospho-tyrosine anti-
body, and the pellet was immunoblotted using antibodies for
TrkA. As expected, NGF stimulation increased pTrkA, pAkt,
and pErk1-2 levels in axons under control conditions, whereas
NGF-mediated phosphorylation of TrkA and downstream effec-
tors was inhibited in axons lacking Tp53inp2 (Figures 2C and
2D), indicating that Tp53inp2 interaction with TrkA receptors me-
diates TrkA signaling in axons. Moreover, immunofluorescence
analysis showed that Tp53inp2 depletion significantly decreasedFigure 2. Tp53inp2 mRNA Interacts with the TrkA Complex to Regulat
(A) RNA immunoprecipitation (RIP) performed on sympathetic neuron lysates usi
predominantly express TrkA) or IgG. The levels of Tp53inp2 were analyzed by qR
**p < 0.01).
(B) RIP performed on mouse cortical neuron lysates using antibodies for pan-Trk
mRNA were analyzed by qRT-PCR. Unpaired two-tailed t test (n = 3, *p < 0.05).
(C) Western blot of axonal lysates from Tp53inp2fl/fl SCG explants infected with an
NGF or left untreated before immunoprecipitation with a phospho-tyrosine (PY2
were immunoblotted as indicated.
(D) Densitometry analysis of data shown in (C). Values are normalized relative to
ANOVA, Tukey’s multiple comparisons test (n = 3–4, *p < 0.05, **p < 0.01).
(E) Left: representative images of pTrkA and tyrosine hydroxylase (TH) immuno
adenovirus expressing either Cre or LacZ. Distal axons were stimulated with NGF
neuron. Ordinary two-way ANOVA, Tukey’s multiple comparisons test (n = 4;
experiment; ***p < 0.001, **p < 0.01).
(F) Representative images of FLAG-TrkA immunostaining in cell bodies (left) and ax
or Cre and co-infected with a FLAG-TrkA adenovirus. Neurons were live-labeled
indicated. Arrows indicate internalized FLAG-TrkA receptors in axons. Scale bar
(G) Quantification of the data in (F). Average fluorescence density was determine
Values are expressed relative to no NGF condition in LacZ-expressing neurons. D
(n = 3, *p < 0.05, **p < 0.01, ***p < 0.001). At least 30–50 cell bodies and 20–30 a
Data are presented as average ± SEM. See also Figure S2.the retrograde appearance of phosphorylated TrkA receptors in
cell bodies of cultured sympathetic neurons lacking Tp53inp2
(Figure 2E).
A key event that mediates NGF-Trk signaling is the ligand-
induced endocytosis of TrkA receptors. The inhibition of local
and retrograde NGF signaling in Tp53inp2-deficient neurons
prompted us to investigate whether Tp53inp2 could influence
TrkA internalization. To this end, we performed a live-cell anti-
body-feeding assay (Yamashita et al., 2017) on Tp53inp2fl/fl
sympathetic neurons co-infected with adenoviruses expressing
either LacZ or Cre and FLAG-TrkA. Robust receptor internaliza-
tion was observed in both cell bodies and axons of control neu-
rons in response to NGF stimulation (Figures 2F and 2G). In
contrast, internalization was markedly attenuated in neurons
lacking Tp53inp2. Similar results were obtained when internal-
ization of endogenous TrkA receptors was probed using a
cell surface biotinylation assay (Houtz et al., 2016). NGF-
induced TrkA internalization was significantly reduced in neu-
rons lacking Tp53inp2 compared with control conditions
(Figure S3A). Loss of Tp53inp2 had no effect on basal levels
of surface TrkA (Figures S3B and S3C) or on total TrkA protein
expression in sympathetic neurons (Figure S3D). Together,
these results indicate that Tp53inp2 regulates NGF-dependent
TrkA internalization.
Tp53inp2 Is a Translationally Repressed mRNA that
Affects Cell Survival and Axon Growth
The findings that the Tp53inp2 transcript interacts with the TrkA
receptor and regulates NGF signaling in sympathetic neurons
prompted us to investigate whether it affected NGF-dependent
axon growth and cell survival. Tp53inp2fl/fl sympathetic neurons
were grown in compartmentalized chambers with NGF added
only to distal axons and infected with either Cre or LacZ adeno-
viruses (Figure S3E). Neurons expressing LacZ showed robust
growth in the presence of NGF (Figures 3A and S3B). In contrast,
NGF-mediated growth was remarkably stunted in neurons lack-
ing Tp53inp2 (Figures 3A and S3B). To determine whether thee NGF Signaling and Endocytosis in Sympathetic Neurons
ng antibodies for pan-Trk (sympathetic neurons grown under NGF stimulation
T-PCR. Ordinary one-way ANOVA, Tukey’s multiple comparisons test (n = 5;
(cortical neurons predominantly express TrkB) or IgG. The levels of Tp53inp2
adenovirus expressing either Cre or LacZ. Isolated axons were stimulated with
0) antibody, followed by immunoblotting for TrkA (pellet). Supernatants (Sup.)
the no neurotrophin condition for LacZ-expressing neurons. Ordinary two-way
staining in cell bodies of Tp53inp2fl/fl sympathetic neurons infected with an
or left unstimulated. Scale bar, 5 mm. Right: quantification of pTrkA puncta per
each data point represents the average of 20–30 neurons per condition per
ons (right) of Tp53inp2fl/fl neurons infectedwith an adenovirus expressing LacZ
with FLAG antibody under non-permeabilizing conditions and NGF-treated as
, 5 mm.
d per square micrometer for each cell body or per micrometer for each axon.
ata are presented as average fluorescence density ± SEM. Two-way ANOVA
xons were analyzed per condition.
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Tp53inp2 loss, adenoviral vectors expressing either full-length
wild-type (WT) Tp53inp2 or a form bearing mutations of all puta-
tive translational start sites within the CDS (ATGNull) were gener-
ated (Figure S3F). Western blotting and qRT-PCR confirmed that
the WT and ATGNull Tp53inp2 transcripts were not translated
despite being transcribed efficiently in PC12 cells (Figures
S3G, S4A, and S4B). When Tp53inp2-deficient neurons were in-
fectedwith either one of the two adenoviral vectors, we observed
that the WT and ATGNull Tp53inp2 were equally efficient in
rescuing axon growth defects induced by the loss of Tp53inp2
(Figures 3C and 3D). Together, these findings indicate that
Tp53inp2 translation is not required for promoting sympathetic
neuron axon growth and support the hypothesis that it may func-
tion outside of its coding capacity.
Next, we asked whether Tp53inp2 loss would compromise
the ability of axonally applied NGF to retrogradely support
neuronal survival. The survival of Tp53inp2fl/fl neurons was stud-
ied in the absence or presence of NGF on distal axons. When
NGF was withdrawn, 80% of neurons in both LacZ- and Cre-in-
fected neurons underwent apoptotic cell death (Figure 3E). NGF
added to the distal axons was sufficient to promote survival of
the majority of LacZ-infected neurons, whereas neurons lacking
Tp53inp2 continued to exhibit significant levels of apoptosis
(Figure 3E; Figure S4C). In line with evidence showing that
NGF applied directly to cell bodies promotes neuronal survival
by an endocytosis-independent mechanism (Riccio et al.,
1997; Ye et al., 2003), we found that, under these conditions,
loss of Tp53inp2 did not increase apoptosis (Figure 3E; Fig-
ure S4C). Thus, Tp53inp2 supports neuronal survival by
regulating endocytosis and retrograde trafficking of NGF-TrkA
receptor complexes.
The Tp53inp2 Transcript Is Necessary for Sympathetic
Neuron Target Innervation
Next, we investigated whether the loss of Tp53inp2 affected
sympathetic neuron survival and growth in vivo. First, in situ hy-
bridization confirmed that Tp53inp2 transcript is expressed in
sympathetic neuron ganglia at high levels from embryonic
day 14.5 (E14.5) until early postnatal stages, a time when
they are highly dependent on NGF for cell survival and axon
growth (Figure 4A). Fluorescence in situ hybridization (FISH)Figure 3. Tp53inp2 Function in Axon Growth Is Translation Independe
(A) Compartmentalized cultures of Tp53inp2fl/fl sympathetic neurons infected wi
axons or deprived of NGF. Shown are representative images of axons immunosta
(B) Average growth rate of axons measured at 24-h intervals for 72 h. Ordinary
represents the average at least 70 axons traced per condition, **p < 0.01, *p < 0
(C) Tp53inp2fl/fl sympathetic neurons cultured in compartmentalized chambers w
of axons immunostained with anti-b-III tubulin 48 h after infection. Scale bar, 100
(D) Average growth rate of axons at 24 h intervals for a total of 72 h. Ordinary t
represents the average of at least 50 axons traced per condition; hinges correspon
the maxima and minima correspond to 5–95 percentiles; ****p < 0.0001).
(E) Left: distal axons of Tp53inp2fl/fl neurons infected with an adenovirus expressin
projected to axonal chambers were identified through the uptake of inert fluor
detected using terminal deoxynucleotidyl transferase dUTP nick end labelling (T
Ordinary two-way ANOVA, Tukey’s multiple comparisons test (n = 3, each data
****p < 0.0001).
Data are presented as average ± SEM. See also Figures S3 and S4.of the 30 UTR of the Tp53inp2 transcript showed punctate
staining in both axons and cell bodies of sympathetic neurons
(Figure 4B). The FISH signal was lost when the assay was per-
formed on Tp53inp2fl/fl neurons infected with an adenoviral
vector expressing the Cre recombinase, confirming the speci-
ficity of the FISH signal.
To generate mice lacking Tp53inp2 in sympathetic neurons,
Tp53inp2fl/fl animals were crossed with transgenic mice ex-
pressing the Cre recombinase under the control of the tyrosine
hydroxylase promoter (Th-Cre;Tp53inp2fl/fl mice; Gong et al.,
2007; Figure S2G), which resulted in efficient deletion (Fig-
ure S4D). Analyses of the SCGs revealed normal numbers of
sympathetic neurons in Th-Cre;Tp53inp2fl/fl mice at E16.5 but
significant cell loss at birth (P0.5) and 3 weeks after birth (P21)
compared with control littermates (Figure 4C). Despite the
absence of neuronal loss at E16.5, sympathetic innervation of
the heart was decreased in the mutant embryos, with a signifi-
cant reduction in both density of innervation and axonal branch-
ing in Th-Cre;Tp53inp2fl/fl embryos compared with control
littermates (Figures 4D and 4E). Taken together, these findings
indicate that Tp53inp2 is required for the development of sympa-
thetic neurons when they are most dependent on NGF for cell
survival and axon growth.
NGF is secreted by the target tissues and acts locally in axons
to support growth. The signal generated by the interaction of
NGF with TrkA receptors is also retrogradely transported to the
cell bodies, where it initiates nuclear events necessary for cell
survival and axon growth (Ascano et al., 2012; Harrington and
Ginty, 2013). We observed that the defects of target innervation
preceded neuronal loss, suggesting that lack of Tp53inp2 pri-
marily affects axon growth in vivo. Thus, in mice lacking
Tp53inp2, neuronal loss was likely due to the axons failing to
reach the target tissues and gain access to adequate levels of
NGF. We cannot exclude, however, that impaired retrograde
NGF signaling from distal axons to the cell bodies may also
play a role.
Crosstalk between NGF Signaling and mRNA
Transcripts in Axons
Neurotrophic signaling is essential for the development of the
sympathetic nervous system. The binding of neurotrophins to
Trk receptors induces a variety of cellular processes requirednt
th an adenovirus expressing LacZ or Cre were either maintained with NGF in
ined with anti-b-III tubulin 48 h after starting the treatments. Scale bar, 100 mm.
two-way ANOVA, Tukey’s multiple comparisons test (n = 3, each data point
.05).
ere infected with adenoviruses as indicated. Shown are representative images
mm.
wo-way ANOVA, Dunnett’s multiple comparisons test (n = 3, each data point
d to the first and third quartiles, the center line corresponds to themedian, and
g LacZ or Cre were stimulated with NGF or deprived of NGF. Neurons that had
escent beads (red) supplied to the axon chambers. Neuronal apoptosis was
UNEL) staining. Scale bar, 5 mm. Right: quantification of neuronal cell death.
point represents the average of at least 30 cells per condition per experiment,
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(Scott-Solomon and Kuruvilla, 2018), which are principally medi-
ated by transcriptional activation and extensive RNA localization
in dendrites and axons (Andreassi et al., 2010, 2019; Cosker
et al., 2016). Although it is well known that neurotrophic signaling
affects gene transcription, asymmetric localization of RNA, and
local translation, whether the opposite event may occur was
unknown.
Our findings add to the small but growing list of mRNA tran-
scripts that, in addition to being translated into proteins, harbor
coding-independent functions (Nam et al., 2016), such as acting
as a sponge for miRNA (Valluy et al., 2015) or as a scaffold for the
formation of protein complexes (Berkovits and Mayr, 2015).
Importantly, the finding that Tp53inp2mRNA acts in a coding-in-
dependent manner in neurons but is translated in other cell types
adds a further layer of complexity to RNA regulation and pro-
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to confer cell-type-specific functions to ubiquitously expressed
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Generation of Tp53inp2fl/fl mutant mice
ES cells containing the Tp53inp2tm1a(KOMP)Mbp targeting vector were obtained from the trans-NIH Knock-Out Mouse Project (KOMP)
Repository (https://www.komp.org/) and used by transgenic core facility at Johns Hopkins University to generate chimeric mice car-
rying the Tp53inp2tm1a allele. Tp53inp2tm1a chimeric male mice were mated to wild-type albino mice (Jackson Laboratory Stock No:
000058). Tp53inp2tm1a mice carry a knockout-first allele, in which a promoterless cassette including LacZ and neo genes were in-
serted in intron 1 of the Tp53inp2 gene. For the sympathetic neuron-specific conditional knockout mice, Tp53inp2tm1a mice were
crossed with a ubiquitously-expressing Flippase line 129S4/SvJaeSor-Gt(ROSA)26Sortm1(FLP1)Dym/J (Jackson Lab) to excise
the LacZ/neo cassette. These mice were then crossed with TH-Cre transgenic mice (gifted by Dr. C. Gerfen NIH) to generate
mice lacking Tp53inp2 in sympathetic neurons. The offspring of these mice were then backcrossed for 2-3 generations to C57/
BL6 mice to obtain offspring of several genotypes including Th-Cre;Tp53inp2fl/fl mice and control Tp53inp2fl/fl littermates.
Primers Tp53inp2Loxp3F and Tp53inp2Loxp3Rwhich span the third loxP site, were used to genotype the Tp53inp2 allele by PCR,
with expected band sizes being 240 bp for wild-type, and 310 bp for the floxed exon. See Table S2 and Key Resources Table for
primer sequences.
Mouse husbandry
Micewere housed in a standard 12:12 light-dark cycle. Both sexeswere used for analyses. The ages ofmice are indicated in the figure
legendsormethods.All procedures relating toanimal careand treatment conformed toJohnsHopkinsUniversity AnimalCare andUse
Committee (ACUC) and NIH guidelines, or the Institutional Animal Care and Use Committee at University College London.
Primary cultures
Superior cervical ganglia (SCG) were dissected from postnatal day 0 or 1 (P0 or P1) Sprague Dawley rats or Tp53inp2fl/fl mice and
immediately plated as explant tissue or enzymatically dissociated and cultured either in compartmentalised chambers or as mass
cultures. Rats of both sexes were used for analyses. For immunocytochemistry, cells were plated on poly-D-lysine-coated (1 mg/ml)
coverslips. Campenot compartmentalised cultures were established as described previously (Riccio et al., 1997). Neurons were
cultured in high-glucose DMEM supplemented with 10%FBS, 2mMglutamine and 100 ng/ml NGF. The antimitotic inhibitor cytosine
arabinoside (10 mM) was provided to minimize non-neuronal, contaminating cell types. When indicated, the cell body cluster was
removed surgically using a scalpel. To withdraw NGF before any stimulation experiments, neurons were placed in DMEM containing
0.5% FBSwith 1:1000 anti-NGF antibody (N6655, Sigma) and BAF (50 mM;MP Biomedical) for 48 hours. For restimulations, neurons
were treated with the indicated concentration of NGF for variable amounts of time as indicated.
Mouse cortical neurons
Cortical neurons were dissected from E15.5 C57BL/6J mouse embryos and enzymatically dissociated. Embryos of both sexes were
used for analyses. Neurons were plated onNunc dishes coatedwith 40 mg/ml poly-D-lysine and 2 mg/ml Laminin and cultured inMEMe3 Neuron 102, 1–11.e1–e8, May 8, 2019
Please cite this article in press as: Crerar et al., Regulation of NGF Signaling by an Axonal Untranslated mRNA, Neuron (2019), https://doi.org/10.1016/
j.neuron.2019.02.011supplemented with 10% FBS and 5% Horse serum. After 6-24 h, culture medium was replaced with Neurobasal medium supple-
mented with B27, 1 mM glutamine, penicillin-streptomycin and 10 mM 5-Fluoro-2ʹdeoxyuridine (FdU, Merck). Cells were cultured
at 37C, 5% CO2 and one day before the experiment, 2/3 plating medium was replaced with medium without B27 (serum starve
conditions).
PC12 cell line
PC12 cell lines were purchased from ATCC. PC12 cells were cultured in DMEM containing 10% FBS, 5% Horse Serum (HS), 2mM
glutamine and grown at 37C10%CO2. Cells were transfectedwith Lipofectamine 2000 in OptiMEMaccording to themanufacturers’
guidelines. For NGF stimulation, cells were cultured in DMEM containing 0.5% FBS, 0.25% HS, 2 mM glutamine and 50 ng/ml NGF
for 4 days under standard growth conditions. Cells were not cultured past 20 passages and sensitivity to NGF stimulation routinely
tested. The Nnr5 PC12 subclone cell line was a kind gift from David Ginty’s Laboratory. Nnr5 cells were cultured in DMEM containing
10% FBS, 5% Horse Serum (HS), 2 mM glutamine and grown at 37C 10% CO2. Cells were transfected with Lipofectamine 2000 in
OptiMEM according to the manufacturers’ guidelines.
HEK293 cell line
The HEK293 cell line was purchased from ATCC and not further authenticated. HEK293 cells were cultured in DMEM containing
5% FBS, penicillin/streptomycin, 2mM glutamine and grown at 37C 5% CO2. Cells were transfected with Lipofectamine 2000 in
OptiMEM according to the manufacturers’ guidelines. Cells were not cultured past 20 passages.
HeLa cell line
The HeLa cell line was purchased from ATCC and not further authenticated. HeLa cells were cultured in MEM containing 5% FBS,
penicillin/streptomycin, 2mM glutamine and grown at 37C 5% CO2. Cells were transfected with Lipofectamine 2000 in OptiMEM
according to the manufacturers’ guidelines. For cyclohexamide analysis, cyclohexamide was added directly to the growth media
at a final concentration of 20 mg/ml and cells weremaintained in culture for times indicated. Cells were not cultured past 20 passages.
METHOD DETAILS
Adenoviral vectors and Plasmids
Rat Tp53inp2CDS was amplified from SCG cDNA and cloned into pCMV-Myc (Clontech) using SalI and BglII to generate Myc-
Tp53inp2CDS plasmid. Tp53inp2CDS-2xFlag was PCR amplified from Myc-Tp53inp2CDS plasmid, using primers that encode
KpnI/XbaI and C terminus 2xFlag tag. Tp53inp2 30UTR 1.2, 2.2 and 3.1 Kb and 50UTR were PCR amplified from RACE clones
(C.A. and A.R., unpublished data) and following NotI/XhoI and BamHI/NheI digestion respectively, were used to replace the IMPA
UTRs in myrdEGFP-IMPA1-L (Andreassi et al., 2010). Mutation of the ATG codons to generate ATGNullCDS was performed on
Myc-Tp53inp2CDS using the QuikChange Site-Directed Mutagenesis kit (Agilent) according to manufacturer’s instructions. The
ATGNullTp53inp2 CDS was then PCR amplified and used to replace the myrdEGFP sequence in the myrdEGFP-Tp53inp2 3.1 Kb
UTR vector to create ATGNull Tp53inp2. Rat Tp53inp2 50UTR+CDS was amplified from SCG cDNA to include endogenous Kozack
sequence, and cloned in place of the ATGNull CDS to generate WT Tp53inp2 vector. To generate adenoviral vectors, WT Tp53inp2
and ATGNull Tp53inp2 were amplified using primers containing KpnI and EcoRV and inserted into pCMV-Shuttle plasmid (Agilent).
Adenoviral vectors were generated using the AdEasy Adenoviral Vector system (Agilent) according to manufacturer’s instruc-
tions. Adenoviral vectors were transfected into HEK293 cells and high-titer viral stocks were prepared using a CsCl gradient.
Tp53inp2CDS-1xFlag and ATGNullCDS-1xFlag were PCR amplified from Myc-Tp53inp2CDS and ATGNullCDS Tp53inp2 respec-
tively and following BamHI/NotI digestion were cloned into pcDNA3.1. Primers used for cloning are listed in Table S2.
RNA isolation and RT-qPCR
Samples were washed with PBS and RNAwas extracted using Trizol reagent following standard manufacturer’s protocol. RNA pellet
was resuspended inwater and contaminating genomic and plasmid DNA removed byDNase digestionwith TURBODNase. PCRwas
performed to amplify Actin gDNA or plasmid DNA prior to reverse transcription to confirm DNase digestion. For cell bodies excised
from explants of sympathetic neurons used in the axonal TrkA signaling assays, RNA was isolated using RNAquesous-Micro Total
RNA Isolation Kit (ThermoFisher) per manufacturer’s protocol with recommended DNase treatment. Total RNA was reverse tran-
scribed using random hexamers and SuperscriptIII reverse transcriptase. RT-qPCR was performed using 20 mL reactions using
MESA Blue (Eurogentec), SYBR green or SYBR Select master mix in the Mastercycler realplex qPCR machine (Eppendorf) or
CFX Connect RT-PCR machine (BIORAD). Reactions were performed in triplicate and a no template control. For absolute quantifi-
cation, a standard curve was included, generated through serial dilutions of known concentration of the DNA amplicon for each
primer set. For relative quantification, the power(2,-Ct) of the experimental gene was normalized by the power(2,-Ct) of a house-
keeping gene and then expressed as fold change relative to a control. Following 40 cycles, a dissociation curve was performed
to assess melting temperature of amplicons. The primers used for RT-qPCR in this study are listed in Table S2.Neuron 102, 1–11.e1–e8, May 8, 2019 e4
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In situ hybridization was performed using a digoxigenin-labeled probe spanning a 450-bp region within exons 2-3 of mouse
Tp53inp2. Embryos or torsos at various developmental stages were fresh frozen in OCT and serially sectioned (12 mm) using a cryo-
stat. Tissue sections from different developmental stages were collected and processed simultaneously. Sections were post-fixed in
4% PFA-PBS, washed in PBS and acetylated with 0.25% acetic anhydride in 0.1 M triethanolamine with 0.9% NaCl. After hybridi-
zation with the labeled RNA probe (2 mg/ml) at 68 C o/n, sections were washed with 0.2x SSC buffer at 65 C, blocked with TBS
containing 1% normal goat serum and then incubated with alkaline phosphatase-labeled anti-DIG antibody (1:5,000; Roche) o/n
at 4 C. The alkaline phosphatase reaction was visualized with NBT/BCIP, rinsed in PBS, fixed in 4% PFA-PBS and mounted in
AquaMount (EMD Chemicals).
smFISH
smFISH was performed as described (Chen et al., 2015; Raj et al., 2008) with minor modifications. Sympathetic neurons were
cultured 3-7 days in vitro on glass coverslips, washed with PBS at room temperature (RT) and fixed using 3.7% PFA-PBS RT
10 min. Cells were permeabilised with 70% EtOH at 4C for 3 h. Coverslips were prehybridized in 2xSSC 10% formamide for
5min RT then incubated at 37Co/nwith Cy3 labeled probe sets designed against Tp53inp2 30UTR (Stellaris probes, Biosearch tech-
nologies) in hybridization buffer (10% formamide, 2x SSC, 10% dextran sulfate and 2 mM vanadyl ribonucleoside). Cells were rinsed
in warm 2x SSC 10% formamide and then 5-(4,6-dichlorotriazinyl) aminofluorescein (DTAF) (Thermo Fischer, D16), a reactive dye that
labels amines in proteins, was added at 1:10,000 (stock 10mg/ml) in GLOX buffer for 10min as a counterstain. Cells were then rinsed
in 2x SSC and mounted using Aquamount containing 1:1000 DAPI.
Neuronal counts
The torsos of Tp53inp2fl/fl or Th-Cre;Tp53inp2fl/flE16.5, P0.5 and P21micewere immersion fixed in 4%PFA-PBS for 4 h (E16.5, P0.5),
or overnight (P21) respectively. The heads were then cryoprotected overnight (for E16.5 and P0.5) or 2 days (P21) in 30% sucrose-
PBS, frozen in OCT and then serially sectioned (12 mm). Tissue sections were stained with a solution containing 0.5% cresyl violet
(Nissl). Cells with characteristic neuronal morphology and visible nucleoli were counted in every fifth Nissl-stained section. For repre-
sentative images, immunohistochemistry was performed on tissue sections. Sections were first blocked in a PBS buffer containing
5% goat serum and 0.1% triton and then incubated overnight in rabbit anti-TH (1:200; Millipore AB152). Following PBS washes; sec-
tions were incubated with anti-rabbit Alexa 488 secondary antibodies (1:200; Life Technologies). Sections were then washed in PBS
and mounted in VectaShield (Vector Laboratories). For practical reasons, analyses were done in a semi-blinded manner, with the
investigator knowing the genotypes prior to the experiment, yet performed the staining and quantification without knowing the ge-
notype of the sample.
Whole-mount diaminobenzidine-TH immunohistochemistry
E16.5 embryonic organs fixed in 4% PFA-PBS were dehydrated by methanol series (50%–80%) and incubated overnight in 20%
dimethylsulfoxide (DMSO)/80% methanol solution containing 3% H2O2 to quench endogenous peroxidase activity. Tissues were
then re-hydrated, blocked o/n in blocking solution (4%BSA/1% Triton X-100 in PBS) using a rabbit anti-TH (Millipore, AB152) diluted
at 1:200 in blocking solution and incubated for 72 h at 4C. Detection was performed with horseradish peroxidase-conjugated
donkey anti-rabbit IgG (GE Healthcare) at 1:200 in blocking solution and incubated o/n at 4C. Visualization was accomplished
with diaminobenzidine. Tissues were re-fixed in 4% paraformaldehyde-PBS, dehydrated by methanol series and cleared with a
2:1 mixture of benzyl benzoate/benzyl alcohol to allow visualization of staining inside the tissue followed by clearing. For practical
reasons, analyses were done in a semi-blindedmanner, with the investigator knowing the genotypes prior to the experiment, yet per-
formed the staining and quantification without knowing the genotype of the sample.
Neuronal survival
SCG neurons isolated from P0.5-P2 Tp53inp2fl/flwere grown in Campenot chambers for 9 days in vitro. NGF was removed and neu-
rons were infected for 48-72 h with either LacZ or Cre adenovirus. FluoSpheres (ThermoFisher: F8789) were added to axonal com-
partments to label projecting neurons. Neurons were starved of NGF and restimulated with 25 ng/ml NGF for 48 h or left deprived. To
detect neuronal death, neurons were fixed in 4% PFA-PBS for 30 min at room temperature followed by permeabilisation with 0.1%
Triton/PBS for 10 min. After extensive PBS washes, dying neurons were visualized using TUNEL staining (Roche: 11684795910) and
mounted in Fluoromount with DAPI (1:1000). Neuronal apoptosis was calculated by determining the percentage of neurons that had
extended to distal compartments that were also TUNEL positive. Between 30-50 neurons were counted per condition in each
experiment.
Axon growth
Compartmentalised neuronal cultures from P0.5 Tp53inp2fl/fl neurons were infected with LacZ or Cre adenovirus after 7-10 days
in vitro after axons had extended into the side compartments. Neurons were either deprived or treated with NGF (100 ng/ml) added
solely to the axonal compartments, and axon growth was measured by capturing phase contrast images of the distal axons over
consecutive 24 h intervals for 3 days, using a Zeiss Axiovert 200 microscope with a Retiga EXi camera. The rate of axonal growthe5 Neuron 102, 1–11.e1–e8, May 8, 2019
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Polysomal Fractionation
SCG neurons were cultured for 7 days under NGF stimulation, then ribosomes were immobilised with 0.1 mg/ml cyclohexamide
added directly to growth media for 3 min at 37C. Cells were washed 2x on ice with cold PBS + 0.1 mg/ml cyclohexamide and lysed
in 10mMTris pH8, 150mMNaCl, 5mMMgCl2, 1%NP40, 10mMVRC, 1%sodium deoxycholate, 40mMDTT, 500U/ml RNaseOUT.
Nuclei were removed by a brief centrifugation and supernatants were supplemented with 0.1 M Tris pH7.5, 150 mM NaCl, 75 mg/ml
cyclohexamide, 1:100 protease inhibitor cocktail, followed by further centrifugation to remove any insoluble material. Lysates were
loaded on top of 15%–40% sucrose gradients, prepared in 10 mM Tris pH7.5, 140 mMNaCl, 1.5 mMMgCl2, 10 mM DTT, 0.1 mg/ml
cyclohexamide, and subjected to ultracentrifugation in Beckman SW41Ti rotor 2 h 4C 25000xg. Nineteen fractions were collected
and digested with proteinase K (100 mg proteinase K, 0.1% SDS, 10 mM EDTA) for 30 min at 37C. To normalize for RNA loss during
extraction, 2.5 ng of in vitro transcribed RNAwas spiked into each fraction prior to phenol:chloroform extraction. Twenty-five per cent
of sample was precipitated for RT-qPCR, and the remainder was precipitated for denaturing agarose gel electrophoresis to assess
quality of the fractionation. RNA was run on 1% agarose MOPS gel under denaturing conditions and the gel was stained with
SYBRGold prior to imaging.
Mass Spectrometry
PC12 cells transfected with a plasmid expressing Myc-Tp53inp2 were washed with cold PBS and lysed in cold RIPA buffer (50 mM
Tris pH 7.4, 150mMNaCl, 0.5% sodium deoxycholate, 1%NP40, 1:100 Protease inhibitor cocktail). Lysates were sheared through a
25 G needle and protein content was quantified by BCA assay according to manufacturer’s instructions (Pierce). 2 mgMyc 9E10 anti-
body (Ab32, Abcam) was conjugated to protein G-Sepharose (GE Healthcare Life Science) o/n rotating at 4C. Bound antibody was
then cross-linked to the beads with 2x30 min RT rotation with 6.5 mg/ml DMP (Thermo Fisher Scientific) in 0.2 M pH8.2 triethanol-
amine, followed by 30 min RT blocking in 100 mM pH8.2 ethanolamine. Beads were washed extensively with PBS and the unbound
antibody eluted with 0.1 M Glycine 10 min RT. Following further PBS washes of beads, 300 mg of protein lysate was added and incu-
bated o/n rotating at 4C. Beads were washed 3 times 10 min RT in wash buffer (10 mM Tris pH7.4, 150 mM NaCl, 1 mM EDTA pH8,
1 mM EGTA pH8, 0.1% Triton X-100) followed by a final PBS wash. Samples were then subjected to on-bead digestion using 200 ng
sequencing grade trypsin in 300 mL 100 mM Tris pH8 15 min 37C. Beads were pelleted by centrifugation and supernatant collected
and analyzed bymass-spectrometry. Lyophilised samples were reconstituted in HPLC-grade water and reduced with 10mMDTT 1h
at 37C, followed by cysteine alkylation (25mM iodoacetamide, 1 h at 37C in the dark); excess iodoacetamidewas quenched by 1 mL
of 100mMDTT. Full tryptic digestion was achieved by an additional overnight incubation in presence of 200 ng of trypsin proteomics
grade. Peptides were purified by strong cation exchange (SCX) extraction tips (Rappsilber et al., 2007), and eluted in 7 mL of 500 mM
ammonium acetate containing 20% acetonitrile v/v. A 10% aliquot of the IP digest was injected for nanoLC-MS/MS analysis in data-
dependent mode.
SCG explants were cultured under NGF stimulation for 7 days and axons surgically dissected from cell body. Axon and cell body
samples were then lysed in cold RIPA buffer, quantified by BCA and analyzed by mass-spectrometry. Proteins were precipitated by
adding four volumes of cold acetone, and by incubating the solution at 20C for 1 h. After a centrifugation step carried out at
12,000xg for 20 min 4C, the supernatant was discarded, and the pellet was resuspended in buffer containing 8 M urea, 100 mM
Tris pH 8.5 and 0.2%w/v SDS. Protein reduction and alkylation was performed as described above. The protein solution was brought
to a final volume of 400 mL by adding HPLC-grade water to reduce urea and SDS concentrations. Finally, 2 mg of trypsin proteomics
grade was added to each sample and incubated o/n at 37C with agitation. The digests were diluted 8-fold in 80% acetonitrile/0.5%
formic acid before being loaded onto SCX extraction tips. For targeted analysis, 30 mL of the initial digest solutions were loaded on
SCX extraction tips and then eluted in 7 mL of 500 mM ammonium acetate containing 20% acetonitrile (v/v); the eluate was evapo-
rated to dryness and reconstituted in 20 mL of mobile phase A (0.1% formic acid, 2% acetonitrile); a 3 mL aliquot was then injected for
nanoscale liquid chromatography coupled to tandem mass spectrometry (nanoLC-MS/MS) analysis.
NanoLC-MS/MS analysis
Proteomic analysis by nanoLC-MS/MSwas essentially performed as described in Taverna et al. (2017). Briefly, peptides were loaded
directly on-column at 500 nL/min and separated at 300 nL/min via a 60-min gradient ramped from 5% to 35%mobile phase B (80%
acetonitrile, 0.1% formic acid); mobile phase A was 2% acetonitrile, 0.1% formic acid. The analytical column, a pulled 75 mm i.d
capillary in-house packed to a length of 12 cm, was connected to a liquid chromatography system (EasyLC 1000, Thermo Fisher
Scientific) and directly interfaced to a quadrupole-orbitrap mass spectrometer Q-Exactive (Thermo Fisher Scientific) via a nanoelec-
trospray interface operating in positive ion mode. Data-dependent acquisition was performed using a top-12 method. Full scan pa-
rameters were: resolution 70,000, m/z range 350-1800. Tandem mass spectrometry parameters were: resolution 17,500, isolation
window 1.6 m/z, maximum injection time 60 ms, AGC target 100,000, normalized collision energy 25, dynamic exclusion 30 s.
Data were processed using Proteome Discoverer 1.3 (Thermo Fisher Scientific). Tandem mass spectrometry data were searched
against the Rattus norvegicus Uniprot database (downloaded on 03/2015) merged with a list of common contaminating proteins
(albumin, trypsin, human keratins). Sequest search parameters were: MS tolerance 20 ppm; MS/MS tolerance 0.02 Da; oxidisedNeuron 102, 1–11.e1–e8, May 8, 2019 e6
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by Percolator (Spivak et al., 2009), integrated in Proteome Discoverer, using default parameters. Protein hits based on two high-con-
fidence peptide identifications (q-value < 0.01) were considered valid.
For targeted mode of analysis, the Orbitrap analyzer was operated in targeted MS/MS mode: a single full MS scan (17,500 reso-
lution, 500,000 target ions) was followed by three targeted MS/MS events on precursors at 420.2 (ALHHAAAPMoxPAR, z = 3), 507.6
(HQGSFIYQPCQR, z = 3), 414.9 (ALHHAAAPMPAR, z = 3) m/z. MS/MS conditions were, in all cases, the following: MS resolution
70,000, maximum injection time 250 ms, isolation window 2.0 m/z, AGC target 200,000, normalized collision energy 25.
RNA Immunoprecipitation
Four mg Trk antibody (Santa Cruz sc7268), HuD antibody (Santa Cruz sc28299), NCAM-L1 antibody (Santa Cruz sc514360) or Mouse
IgG antibody (Santa Cruz sc2027) were incubatedwith prewashed protein A/G agarose beads (Santa Cruz) in a PBS buffer containing
1 mg/ml heparin and 1% BSA for 2 h 4C, and then washed with wash buffer (50 mM Tris pH8, 150 mM NaCl, 1% Triton X-100). Rat
SCG neurons or mouse cortical neurons were cultured 5-7 days in vitro and then, for SCG cultures, deprived of NGF for 24 h before
stimulating for 30 min with NGF or leaving unstimulated. Cultures were washed with PBS and lysed in Buffer A (50 mM Tris pH8,
150 mMNaCl, 1% Triton X-100, 1:100 Protease inhibitor cocktail, 500 U/ml RNaseOUT) 10 min 4C. Insoluble material was removed
by centrifugation, a 10% fraction saved for total input, and lysates were incubated with antibody conjugated beads for 1 h at 4C in
wash buffer containing 0.2 mg/ml heparin. Beads were washed 3 times with wash buffer 10 min 4C followed by elution of RNA in
extraction buffer (0.2 M NaAcetate, 1 mM EDTA, 0.2% SDS) for 5 min at 70C. RNA was purified from inputs and immunocomplexes
using PureLink RNA Micro Scale Kit according to manufacturer’s instructions and analyzed by qRT-PCR.
Immunoprecipitation and immunoblotting analyses
SCGs were isolated from P0-P3 Tp53inp2fl/flmice and grown as explant cultures. After 7-8 days in vitro, NGF was removed and neu-
rons infected for 48 h with either LacZ or Cre adenovirus. Cell bodies were surgically removed and the axons were stimulated with
50 ng/ml NGF for 30 min or treated with anti-NGF antibody. Three to seven explants per condition were lysed in RIPA buffer with
2.5 mM sodium pyrophosphate, 50 mM sodium fluoride, 1 mM sodium orthovanadate and protease inhibitors. To detect P-TrkA,
axon lysates were subjected to immunoprecipitation with anti-phosphotyrosine antibody (PY-20; 4 ml; Sigma-Aldrich) and incubated
with Protein G-Plus (Santa Cruz: sc-2002) agarose beads. Immunoprecipitates were then immunoblotted for TrkA (1:1000 Millipore;
06-574). The supernatants from the immunoprecipitations were subjected to immunoblotting with pAkt (1:1000 Cell Signaling; 9271),
pErk1/2 (1:1000 Cell signaling; 9106) and p85 antibodies (1:1000 Upstate Biotechnology, 06-195). All immunoblots were visualized
with ECL Plus Detection Reagent (GE Healthcare) and scanned with a Typhoon 9410 Variable Mode Imager (GE Healthcare).
For Trk and HuD immunoprecipitations, PC12 cells or SCG neurons were lysed in RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM
NaCl, 1%NP-40, 0.5%Sodium deoxycholate, 0.1%SDS, 1mMEDTA, Protease Inhibitors Cocktail) for 10min on ice, and then insol-
uble material was removed by centrifugation. Lysates were pre-cleared and 0.5-1 mg of lysate was incubated o/n at 4Cwith 2 mg of
indicated antibody. Immuno-complexes were precipitated by the addition of protein A-agarose beads at 4C for 2 h, and then beads
washed extensively with RIPA buffer. Samples were eluted from beads by boiling at 95C in 1x LDS buffer + 10% b-mercaptoethanol
and resolved on polyacrylamide gels.
In all other western blots, cell lysates were prepared in 1x NuPAGE LDS buffer + 10% b-mercaptoethanol, mechanically disrupted
by syringing and boiled at 95C for 5 min before loading. The primary antibodies used were goat anti-Tp53inp2 (1:250 Santa Cruz
sc85972), rabbit anti-Tp53inp2 (1:200 generated by Riccio Laboratory) rabbit anti-Tp53inp2 (1:500 a kind gift from Zorzano Labora-
tory; Baumgartner et al., 2007), rabbit anti-Tp53inp2 (1:1000 Sigma AB4502917) mouse anti-Flag (1:1000 Sigma F3165), rabbit anti-
Flag (1:1000 Sigma F7425), goat anti-Hsp90 (1:1000 Santa Cruz sc1055), mouse anti-Myc (1:2000 Upstate 05-724), rabbit anti-p85
PI3K (1:1000 Upstate 06-497), mouse anti-a-Tubulin (1:10000 Sigma T9026), chicken anti-GFP (1:5000 Abcam ab13970) mouse anti-
mCherry (1:4000 Abcam ab125096), mouse anti-HuD (1:1000 Santa Cruz sc28299), mouse anti-Trk (1:1000 Santa Cruz sc7268)
mouse anti-NCAM (1:1000 Santa cruz sc514360). The HRP-conjugated secondary antibodies used were anti-mouse (GE Healthcare
life sciences) anti-rabbit (GEHealthcare life sciences), anti-goat (Sigma), anti-chicken (Sigma). Signal was detected using ECL or ECL
Prime (GE Healthcare Life Science) and exposing membrane to Amersham Hyperfilm (GE Healthcare Life Science).
pTrkA Immunostaining
SCG neurons isolated fromP0-P3 Tp53inp2fl/flmicewere grown in Campenot chambers for 8-10 days in vitro. NGFwas removed and
neurons infected for 48 h with either LacZ or Cre adenovirus. FluoSpheres were added to axonal compartment to label projected
neurons. Distal axons were treated for 4 h with either 50 ng/ml NGF or anti-NGF antibody. To detect pTrkA in the cell bodies induced
by retrograde NGF signal, neurons were fixed in 4%PFA-PBS for 30 min at room temperature and blocked in a PBS buffer containing
5%Goat Serum and 0.1% TritonX for 1 h. Neurons were incubated with rabbit anti-pTrkA (1:1000; Cell Signaling Technology, 4168S)
and mouse anti-TH antibodies (1:1000, Sigma, T2928) in a PBS buffer containing 1% Goat Serum and 0.1% Triton, o/n at 4C.
Following extensive washes with PBS, neurons were incubated with fluorescently conjugated anti-rabbit (ThermoFisher, A11008)
and anti-mouse antibodies (Thermo Fisher, A21240) secondary antibodies at 1:1000 dilution, 37C for 2 h. Slides were mounted
in Fluoromount (Sigma) with DAPI. Images representing 0.8 mm slices were acquired using a Zeiss LSM 700 confocal scanning
microscope. The same confocal settings were used to acquire all images taken from a single experiment. For practical reasons,e7 Neuron 102, 1–11.e1–e8, May 8, 2019
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staining and quantification without knowing the genotype of the sample.Total pTrkA positive punctae were quantified using Particle
Analyses for 20-30 neurons per condition.
Analyses of surface TrkA, receptor endocytosis, and total TrkA
Live-cell antibody feeding to monitor surface TrkA and receptor endocytosis were performed as previously described (Yamashita
et al., 2017). Cultured sympathetic neurons isolated from Tp53inp2fl/fl mice were infected o/n with a doxycycline-inducible Flag-
TrkA adenovirus, and either LacZ or Cre adenovirus. Neurons were then treated with doxycycline (200 ng/mL, 18 hr) to induce
Flag-TrkA expression. Surface Flag-TrkA was labeled by incubating neurons with anti-Flag antibody (Sigma, F7425, 1:500) in PBS
for 30 mins at 4C, in the absence of NGF. Excess antibody was washed off with ice-cold PBS, and neurons either immediately fixed
with 4%PFA/PBS for 30mins to assess surface Flag-TrkA distribution, or treated with anti-NGF or NGF (50 ng/mL) for another 30min
to assess receptor internalization. Following treatment with NGF or anti-NGF, neurons were returned to 4C and quickly washed in
ice-cold acidic buffer (0.2 M acetic acid, 0.5 M NaCl, pH 3.0) to strip surface-bound Flag antibodies and fixed. Neurons were per-
meabilised with 0.1% Triton X-100/5%Normal Goat Serum/PBS and receptors visualized by incubation with anti-rabbit-Alexa 488
secondary antibody. Neuronal morphology was visualized by co-staining with anti-b-tubulin III antibody (Sigma-Aldrich, T8660,
1:1000). Images representing 0.8 mm slices were acquired using a Zeiss LSM 700 confocal scanningmicroscope. The same confocal
settings were used to acquire all images taken from a single experiment. For practical reasons, analyses were done in a semi-blinded
manner, with the investigator knowing the genotypes prior to the experiment, yet performed the staining and quantification without
knowing the genotype of the sample. Surface Flag-TrkA receptor distribution was analyzed bymeasuring the integrated fluorescence
values along the longest axis of the cell body using line-plot in ImageJ and normalized to the total cell body fluorescence intensity.
Intracellular accumulation of Flag-TrkA receptors in cell bodies were quantified as the number of FLAG-immunopositive punctae per
neuron. Cell bodies were visualized using the GFP signal and FLAG signals overlapping with GFP fluorescence were defined as inter-
nalized soma surface-derived receptors. To assess Flag-TrkA internalization, cell bodies or axons were outlined using b-tubulin III
immunostaining and internalized receptors calculated as integrated density of Alexa 488 pixels per mm2 (cell bodies) or Alexa 488
pixels per mm (axons).
Cell surface biotinylation was performed on Tp53inp2fl/fl neurons as previously described (Houtz et al., 2016). Briefly, Tp53inp2fl/fl
neurons, infected with either LacZ or Cre adenoviruses, were deprived of NGF in the media after a culture period of 8-10 d.i.v. and
biotinylated at 4Cwith a reversiblemembrane-impermeable formof biotin (EZ-Link NHS-SS-Biotin, 1.5mg/ml in PBS, ThermoFisher
Scientific, Cat# 21441) for 30 min. Cells were washed briefly with PBS containing 50 mM glycine (Sigma) to remove remaining un-
conjugated biotin, and then moved to 37C and stimulated with NGF (50 ng/mL) for 30 min to promote internalization. Cells were
returned to 4C, the remaining biotinylated surface receptors were stripped of their biotin tag with 50 mM glutathione (Sigma), fol-
lowed by two washes with 50 mM iodoacetamide (Sigma) to quench excess glutathione. Cells were lysed with 500 ml of RIPA buffer
(50mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% deoxycholate), and supernatants subjected to precipitation with
40 ml-immobilized neutravidin agarose beads (ThermoFisher Scientific) and immunoblotted for TrkA.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are expressed as average ± SEM. One-way ANOVA, two-way ANOVA, Mann-Whitney two-tailed test, or t test were used as
indicated in the figure legends to test for statistical significance using GraphPad Prism. n values are indicated in the corresponding
figure legends. Significance was placed at p < 0.05 unless otherwise noted in the figure legends. Statistical methods were not used to
determine sample size, but sample size was selected based on similar studies within the field.
DATA AND SOFTWARE AVAILABILITY
The datasets generated during the current study are available from the corresponding author on reasonable request.Neuron 102, 1–11.e1–e8, May 8, 2019 e8
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Figure S1: Tp53inp2 translation is repressed in sympathetic neurons. Related 
to Figure 1. A, Top ten most abundant axonal transcripts as identified by 3’end 
RNAseq screen performed on axons and cell bodies of sympathetic neurons. B, 
(upper) 3’end Seq tracks of Tp53inp2 mRNA from cell body and axonal mRNA and 
(lower) schematic of Ensembl transcript ID ENSRNOT00000055310, red arrowhead 
represent the positions of AATAAA PAS hexamer, black arrows represent the 
position of proximal (P) and distal (D) primers used for analysis in Figure S1J. C, 
Western blotting analysis of Tp53inp2, Myc and PI3K subunit of p85 on PC12 lysates 
transfected with Myc-Tp53inp2 CDS, and axonal and cell body lysates of 
sympathetic neurons. See also (Figure 1A,B). D, Western blot analysis of PC12 
cells transfected with mycTp53inp2, PC12 cells ±NGF stimulation, SCG sympathetic 
neurons and Nnr5 PC12 cell line. E, Western blot analysis of HeLa lysates co-
transfected with mycTp53inp2CDS and Tp53inp2 siRNA, as indicated (n=3). (See 
also Figure 1B). F, Polysomal fractionation profile of β-actin mRNA from sympathetic 
neurons. Values are expressed as percentage of total β-actin mRNA (n=3). (See also 
Figure 1C). G, Pseudo-Selected Reaction Monitoring traces for the detection of a 
Tp53inp2 tryptic peptide in cultured sympathetic neuron axon or cell body samples, 
and in immunoprecipitated mycTp53inp2 control. The 5 traces represent the 5 most 
abundant fragments of the Tp53inp2 peptide HQGSFIYQPCQR (m/z 507.6). Arrows 
indicate where at least three transitions are detected at the same retention time. Top 
value on trace=retention value, bottom value=m/z. (See also Figure 1D-F). H, 
Densitometry of GFP protein levels normalised by mCherry levels and expressed as 
percentage of the mean GFP protein amount of the 1.2 Kb construct. Data presented 
as average ±s.e.m.; Ordinary one-way ANOVA Tukey’s multiple comparisons (n=5, 
****P<0.0001). See also (Figure 1G). I, Relative GFP mRNA expression in PC12 
cells transfected with GFP constructs carrying Tp53inp2 3’UTR of indicated length 
(Kb). mRNA levels were normalised to levels of mCherry mRNA and expressed as 
percentage of the mean GFP amount of the 1.2 Kb construct. Data are presented as 
	 2	
averages ±s.e.m., ordinary one-way Tukey’s multiple comparisons ANOVA (n=5, 
*P<0.05 **P<0.01 n.s. = not statistically significant). (See also Figure 1G). J, RT-
qPCR analysis of Tp53inp2 mRNA expression in rat sympathetic neurons and HeLa 
cell lysate. Primers proximal and distal of the internal polyA site in rat Tp53inp2 
3’UTR (see Figure S1B) were used for analysis and values are normalised to 
percentage expression of the respective proximal primer set. Data are presented as 
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Figure S2: Tp53inp2 mRNA interacts with the TrkA complex to regulate its 
function. Related to Figure 2. A, RNA immunoprecipitation performed on 
sympathetic neuron lysates using antibodies for pan-Trk, or normal mouse IgG. 
Levels of Tp53inp2 were analysed by RT-qPCR, normalised as fraction of total input 
and expressed as fold over IgG. Data are presented as average ±s.e.m. multiple t-
test (n=4, **P<0.01 n.s. = not statistically significant). (See also Figure 2A). B, RNA 
immunoprecipitation performed on sympathetic neuron lysates using antibodies for 
HuD or normal mouse IgG. Levels of Tp53inp2 or Impa-L mRNAs were analysed by 
RT-qPCR, normalised as fraction of total input and expressed as fold of control IgG. 
Data are presented as average ±s.e.m. multiple t-test (n=4, ****P<0.0001). C, 
Western blot analysis of HuD immunoprecipitation in sympathetic neurons. D, 
Western blot analysis of Trk co-immunoprecipitation experiments in PC12 cell 
lysates. HuD co-immuno-precipitates with Trk. Images separated by vertical lines are 
taken from the same exposure. Low exposure of HuD in input sample shows 
presence of duplet (n=3). E, RNA immunoprecipitation performed on sympathetic 
neuron lysates using antibodies for NCAM or normal mouse IgG. Levels of Tp53inp2 
were analysed by RT-qPCR and expressed as fold over IgG. Data are presented as 
average ±s.e.m. Unpaired two tailed T-test with Welch’s correction (n=4, n.s. = not 
statistically significant). F, Western blot analysis of NCAM immunoprecipitation in two 
representative sympathetic neuron lysates. G, Schematic for the generation of the 
transgenic Tp53inp2fl/fl and Th-Cre;Tp53inp2fl/fl mice. Tp53inp2tm1a mice were first 
crossed with the ubiquitously-expressing Flippase 129S4/SvJaeSor-
Gt(ROSA)26Sortm1(FLP1)Dym/J to excise the LacZ/neo cassette, and then with Th-
Cre transgenic mice to generate mice lacking Tp53inp2 in sympathetic neurons (Th-
Cre;Tp53inp2fl/fl mice). Exons are indicated by yellow bars, with UTRs as projecting 
thin yellow bars. Location of primers used for genotyping indicated as F and R 
labelled black arrows. H, Tp53inp2 mRNA levels in axons of Tp53inp2fl/fl SCG 
explants infected with adenovirus expressing LacZ or Cre. Values are normalised by 
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levels of 18S rRNA and expressed as percentage of LacZ infected neurons values. 
Data are presented as average ±s.e.m. one-sample t-test (n=3 ***P<0.001). (See 








































































































































Figure S3: Tp53inp2 function in axon growth is translation independent. 
Related to Figure 2 and 3. A, Membrane proteins in mass cultures of Tp53inp2fl/fl 
neurons, infected with either LacZ or Cre, were subjected to cell surface biotinylation. 
After NGF stimulation for 30 minutes, surface biotin was stripped off, and internalized 
TrkA receptors were detected by neutravidin precipitation and TrkA immunoblotting 
(Left). Supernatants were probed for p85 as a loading control. Densitometry analysis 
(Right) of internalized biotinylated TrkA levels, normalised by p85. Values expressed 
as relative to LacZ-expressing neurons. Data presented as average ± s.e.m., 
unpaired two-tailed t-test (**P<0.01 n=3). See also (Figure 2F, G). B, Representative 
images of surface Flag-TrkA immunostaining in Tp53inp2fl/fl sympathetic neurons 
infected with adenovirus expressing Cre or LacZ and co-infected with adenovirus 
expressing Flag-TrkA. Neurons were live-labelled with Flag antibody in the absence 
of NGF at 4°C. C, Surface Flag-TrkA receptor distribution in Tp53inp2fl/fl sympathetic 
neurons infected with adenovirus expressing LacZ or Cre was analysed by 
measuring the integrated fluorescence values along the longest axis of the cell body 
using line-plot in ImageJ and normalized to the total cell body fluorescence intensity. 
Data are presented as averages ± s.e.m. Mann-Whitney two-tailed test (P=0.1089, 
n=3 with at least 15-20 cells analysed per condition per experiment). D, Western blot 
analysis (Left) of endogenous TrkA expression in Tp53inp2fl/fl neurons infected with 
LacZ and Cre adenoviruses, with p85 as a loading control. Densitometry analyses 
(Right) of TrkA protein levels normalized to p85. Data presented as average ± s.e.m. 
Unpaired two-tailed t-test (n.s.= not significant, n=3). E, Schematic representation of 
compartmentalised chambers. Neurons are plated in central compartment and axons 
project into the lateral compartments. For adenoviral infections, adenovirus is 
supplied to the central compartment after axons start projecting into the lateral 
compartments. See also (Figure 2 and 3). F, Nucleotide sequence of ATGNull CDS 
mutant sequence of Tp53inp2 rat mRNA. Mutations are indicated by red underlined 
characters; deletion of adenosine from initial translational start codon and 
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substitution of adenosine to cytosine in subsequent in-frame ATG codons. See also 
(Figure 3C, D). G, Western blotting on lysates of PC12 cells transfected with 
Tp53inp2CDS-1xFlag, ATGNullCDS-1xFlag or pcDNA3.1 as control. Cells were also 
transfected with siRNA for Tp53inp2 mRNA or non-targeting control siRNA (n=3). 



























































































































































Figure S4: Tp53inp2 is essential for the growth of NGF-responsive sympathetic 
neurons. Related to Figure 3 and 4. A, Western blotting analysis of PC12 cell 
lysates transfected with vectors expressing mycTp53inp2CDS, WildType Tp53inp2 
mRNA, full length ATGNull Tp53inp2 or empty vector. (n=3). See also (Figure 3C, 
D). B, Expression levels of Tp53inp2 mRNA in PC12 cells transfected with vectors 
expressing full length WildType Tp53inp2 mRNA, full length ATGNull Tp53inp2 or 
empty vector, as a control. Levels of Tp53inp2 mRNA were analysed by RT-qPCR, 
normalised to levels of β-actin mRNA and expressed as fold over control Tp53inp2 
mRNA levels. Data are presented as average ±s.e.m. Ordinary one-way ANOVA 
(n=4,****P<0.0001). (See Figure 3C, D). C, (Left) Cell bodies of compartmentalised 
cultures of Tp53inp2fl/fl neurons infected with adenovirus expressing LacZ or Cre 
were treated with NGF (25 ng/ml) or anti-NGF antibody for 48 hours. Neurons that 
had projected to axonal chambers were identified through the uptake of fluorescent 
beads (red) supplied to the axon chambers. Neuronal apoptosis was detected using 
TUNEL staining. Scale bar 5 µm. (Right) Quantification of neuronal cell death in 
Tp53inp2fl/fl sympathetic neurons expressing Cre or LacZ and NGF supplied to the 
cell bodies (cb). Data are presented as averages ± s.e.m Ordinary two-way ANOVA 
Tukey’s multiple comparisons, (n=3, each data point represents the average of at 
least 30 cells per condition per experiment, ****P<0.0001). See also (Figure 3E). D, 
SCGs were harvested from P0.5 Th-Cre;Tp53inp2fl/fl mice and Tp53inp2fl/fl 
littermates. Levels of Tp53inp2 mRNA were analysed by RT-qPCR, normalised by 
GAPDH and calculated as percentage of the Tp53inp2fl/fl values. Data are presented 
as average ±s.e.m. unpaired two-tailed t-test (n=4 mice per genotype ****P<0.0001). 
(See also Figure 4). 		
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Table S1: List of Tp53inp2 proteotypic peptides identified in Tp53inp2 immuno-
precipitate. Related to Figure 1 	






























Tp53inp2 tryptic peptides identified by data-dependent nanoLC-MS/MS analysis on a 
Tp53inp2 immunoprecipitate. Experimental m/z, mass error, chromatographic 
retention time, peptide score according to the Sequest search engine and suitable 
fragments for pseudo-SRM targeted analysis (based on both ion abundance and 
specificity) are reported. 		 	
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Table S2: List of primers used in this study. Related to STAR Methods 
Application Primer Name Primer Sequences 
Genotyping Tp53inp2LoxP3F GATCAGGACCTCAGCGATGG 
Genotyping Tp53inp2LoxP3R GCACCTGGCACAGGTAACTA 
Cloning NotI3UTRTpF AAT ATA GCG GCC GCG CGC CCC CGC TG 
Cloning XhoI3UTRTp1.2R TGC TTA CTC GAG CTC TAC CCA GGA GTG TTT ATT CC 
Cloning XhoI3UTRTp2.2R TGC TTA CTC GAG GCA GGA GAC TGA GTA GTG TTG G 
Cloning XhoI3UTRTp3.1R CTG GCT CGA GTT AAT GTG CTT TAA ATA GAT TTT TAT TTG 
Cloning NheI5UTRTpF TAA GCA GCT AGC ACA ATC AGC TGT TGA AGC G 
Cloning BamHI5UTRTpR TCT TAG GAT CCG GTC AGC GGG TGA AGC 
Cloning BamHINullCDSF TGA GGA TCC TGT TCC AGC GCT TCA CC 
Cloning NotITpCDSR TTC GGC GGC CGC TCA GTA GTT GAA CTG GCG 
Cloning KpnIRescueF ACA GGT ACC ACA ATC AGC TGT TGA AGC 
Cloning EcoRVRescueR GAC GAT ATC TGT GCT TTA AAT AGA T 
Cloning BamHINullCDSF TCA GGA TCC TGT TCC AGC GCT TC 
Cloning BamHITpCDSF TTC AGG ATC CAT GTT CCA GCG CTT C 
Cloning NotITpCDS1xFlagR 
AAT GCG GCC GCT CAC TTG TCG TCA TCG TCT TTG TAG TCG TAG 
TTG AAC TGG CG 
Cloning XbaITpCDS2xFlagR 
CGT ATC TAG ATC ACT TAT CGT CGT CAT CCT TGT AAT CCT TAT 
CGT CGT CAT CCT TGT AAT CGT AGT TGA ACT GGC 
Cloning KpnITpCDSF GAT CGG TAC CAT ATG TT CCA GCG CTT CAC C 
RT-qPCR qTpF1 GCA CCT CCT GAA GAC TCC AA 
RT-qPCR qTpR1 GGG TAA CAA ACC AGC TCT CG 
RT-qPCR qTpF2 GAA GCT GCC TTG CCT GAT C 
RT-qPCR qTpR2 CCG TTG CAA CAC TTT AGC AC 
RT-qPCR qTpF3 CCT CAT TGA GCA TCC CAG CA 
RT-qPCR qTpR3 CAG CTC TCC ATC GCT GAG G 
RT-qPCR qTpUTRF1 AAC CTT GTT GCT GTC CCA AG 





GGG CTC CTT CTT GCT GCT TA 
CCT GCT CCC TTC TGC TTC TC 
RT-qPCR qβActF1 ATG GAT GAC GAT ATC GCT GCG  
RT-qPCR qβActR1 GGT GAC AAT GCC GTG TTC AAT  
RT-qPCR qβActF2 TGT CCC TGT ATG CCT CTG GT 
RT-qPCR qβActR2 ATG TCA CGC ACG ATT TCC CT 
RT-qPCR qGFPF1 GAC GTA AAC GGC CAC AAG TT 
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RT-qPCR qGFPR1 AAG TCG TGC TGC TTC ATG TG 
RT-qPCR qIVTF1 GTG TTA ACT TCC GAC TCC TCG C 
RT-qPCR qIVTR1 GTG ATG TCA AAC GAC GCA GC 
RT-qPCR qmCherryF1 GAG GGC ACC CAG ACC GCC AA 
RT-qPCR qmCherryR1 ACG CCG CCG TCC TCG AAG TT 
RT-qPCR qMsTpF1 GAG GAG GAT GAA GTG GAC GG 
RT-qPCR qMsTpR1 GGG AGG GGT AAC AAA CCA GC 
RT-qPCR qMsTpF2 GAG GAT GAA GTG GAC GGC TG 






GAA GTG GAT GGC TGG CTC AT 






CTC CCC TTC CTT CTG CCT TG 





TAG GGC CCC AGT AGT TGA CA 
GGC AGT GAG GAG TAG GCA AG 
RT-qPCR qGAPDHF1 CCT GCA CCA CCA ACT GCT TA 
RT-qPCR qGAPDHR1 CCA CGA TGC CAA AGT TGT CA 
RT-qPCR q18sF1 CGC CGC TAG AGG TGA AAT TC 
RT-qPCR q18sR1 TTG GCA AAT GCT TTC GCT C 		
